Table S1.

SUA changes of the ARBs–IRB switch group by the pre-treatment of ARBs

	Number
	> baseline	= baseline	< baseline
SUA at 6–12 months of the ARBs pre-treatment
Candesartan	15	0	12
Telmisartan	9	2	10
Valsartan	2	0	1
Olmesartan	1	0	1
Sum	27	2	24

Note: Baseline means the average of values between ARBs-naïve examinations and the onset of ARBs.

Abbreviations: ARB, angiotensin II receptor blockers; IRB, irbesartan; SUA, serum uric acid.